The Latest Pharmaceutical Packaging Industry Statistics Explained
The global pharmaceutical packaging market size was valued at USD 99.9 billion in 2020.
The statistic that the global pharmaceutical packaging market size was valued at USD 99.9 billion in 2020 indicates the total revenue generated from the sales of packaging materials and solutions specifically designed for the pharmaceutical industry on a global scale during that year. This figure sheds light on the significant economic impact of the pharmaceutical packaging sector and reflects the increasing demand for these specialized products to ensure the safe and efficient delivery of pharmaceutical products to consumers worldwide. The data underscores the importance of packaging in the pharmaceutical industry and highlights the substantial market opportunity for companies operating in this sector.
The global pharmaceutical packaging market is forecasted to reach USD 142.59 billion by 2025.
The statistic, stating that the global pharmaceutical packaging market is estimated to reach USD 142.59 billion by the year 2025, highlights the anticipated growth and significance of this industry in the near future. This forecasted market value represents the projected total revenue generated from the sales and manufacturing of pharmaceutical packaging products worldwide. Factors contributing to this growth may include the increasing demand for pharmaceutical products, advancements in packaging technology, regulatory requirements, and the expanding pharmaceutical industry. The statistic suggests that pharmaceutical packaging will continue to be a critical component of the healthcare sector, serving a crucial role in ensuring the safety, quality, and effectiveness of pharmaceutical products for consumers globally.
North America accounted for the largest market for pharmaceutical packaging in 2020.
The statistic ‘North America accounted for the largest market for pharmaceutical packaging in 2020’ indicates that among all the regions worldwide, North America had the highest market share in terms of pharmaceutical packaging sales and revenue in the year 2020. This suggests that the pharmaceutical packaging industry in North America was the most prominent and profitable compared to other regions during that period. Factors such as advanced healthcare infrastructure, stringent regulations, high demand for pharmaceutical products, and a well-established pharmaceutical industry in North America likely contributed to its market leadership in pharmaceutical packaging in 2020.
The forecasted CAGR of the pharmaceutical packaging industry from 2021-2028 is 8.5%.
The forecasted Compound Annual Growth Rate (CAGR) of the pharmaceutical packaging industry from 2021 to 2028 is projected to be 8.5%. This statistic indicates that, on average, the industry is expected to grow by 8.5% annually over the specified time period. A CAGR of 8.5% suggests a healthy growth rate for the pharmaceutical packaging sector, reflecting opportunities for innovation, new product developments, market expansion, and increased demand for pharmaceutical products. This forecast provides valuable insights for industry stakeholders, investors, and policymakers in understanding the potential trajectory of the pharmaceutical packaging market in the coming years.
Plastic & polymers were most used material for pharmaceutical packaging in 2020, capturing over 50% market share.
The statistic indicates that in 2020, plastic and polymers were the predominant materials used for pharmaceutical packaging, accounting for more than half of the market share. This suggests that these materials were favored over others such as glass, metal, or paper for packaging pharmaceutical products. The dominance of plastic and polymers in pharmaceutical packaging may be attributed to their versatility, durability, and cost-effectiveness, which make them suitable for protecting and preserving a wide range of medication types. The high market share captured by these materials highlights their importance in the pharmaceutical industry and the ongoing preference for using them in packaging applications.
Plastic bottles accounted for the largest segment size in the pharmaceutical packaging market in 2020, which held about 30% of the total market.
This statistic indicates that plastic bottles were the most dominant packaging material within the pharmaceutical packaging market in 2020, constituting approximately 30% of the total market share. This suggests that pharmaceutical companies predominantly utilized plastic bottles for packaging their products during that year, which might be attributed to factors such as cost-effectiveness, durability, ease of manufacturing, and recyclability. The substantial market share held by plastic bottles underscores their significant role in the pharmaceutical industry’s packaging landscape and highlights the importance of assessing the environmental impact of such packaging materials in terms of sustainability and waste management.
The Asia-Pacific pharmaceutical packaging market is expected to grow at the highest CAGR during the forecast period.
This statistic indicates that the Asia-Pacific pharmaceutical packaging market is projected to experience the highest Compound Annual Growth Rate (CAGR) among all regions over the forecast period. This suggests that the demand for pharmaceutical packaging within the Asia-Pacific region is expected to increase at a faster rate compared to other regions globally. Factors contributing to this growth may include a rising population, increasing healthcare expenditures, advancements in healthcare infrastructure, and the expansion of pharmaceutical industries in countries within the Asia-Pacific region. Consequently, companies operating in the pharmaceutical packaging sector may find lucrative opportunities for market expansion and investment within the Asia-Pacific region.
The increasing adoption of prefillable syringes is propelling the market growth of pharmaceutical packaging.
The statistic suggests that the pharmaceutical packaging market is experiencing growth, which is being driven by the rising popularity of prefilled syringes. Prefillable syringes provide numerous advantages such as convenience, safety, and precise dosing, making them increasingly favored by healthcare professionals and patients. This trend is boosting the demand for pharmaceutical packaging specifically designed to accommodate and protect prefilled syringes, driving market growth in this sector. The statistic indicates a strong correlation between the adoption of prefilled syringes and the expansion of the pharmaceutical packaging market, highlighting the importance of catering to this growing trend within the industry.
In 2019, the pharmaceutical drugs demand accounted for over 55% of the pharmaceutical packaging market.
The statistic indicates that in 2019, pharmaceutical drugs were the dominant driver of demand in the pharmaceutical packaging market, accounting for more than half (55%) of the overall market demand. This suggests that pharmaceutical packaging manufacturers primarily catered to the needs of the pharmaceutical drugs industry, reflecting the significance of pharmaceutical products in driving the growth and revenue of the packaging sector. The high demand for pharmaceutical packaging in relation to drugs may be attributed to factors such as increasing healthcare expenditures, rising global population, and advancements in drug manufacturing technologies. This statistic underscores the strong connection between the pharmaceutical industry and its packaging counterpart, highlighting the important role packaging plays in ensuring the safety, efficacy, and compliance of pharmaceutical products.
Europe’s pharmaceutical packaging market was worth USD 24.86 billion in 2020.
The statistic that Europe’s pharmaceutical packaging market was worth USD 24.86 billion in 2020 indicates the total value of sales generated by the packaging industry specifically within the pharmaceutical sector in Europe during that year. This figure represents the combined revenues from various types of packaging materials and solutions used to protect, preserve, and present pharmaceutical products. The sizeable market value highlights the significance and demand for quality packaging in the pharmaceutical industry within the European region, reflecting the substantial investments made by pharmaceutical companies in ensuring the safety, efficiency, and compliance of their products.
Injectable drugs segment is predicted to witness 8.6% CAGR in the period of 2021-2027 in the pharmaceutical packaging market.
This statistic indicates that the segment of injectable drugs is expected to experience a Compound Annual Growth Rate (CAGR) of 8.6% during the period from 2021 to 2027 within the pharmaceutical packaging market. This means that the demand for packaging materials and solutions specifically tailored for injectable drugs is projected to steadily increase at an annual growth rate of 8.6% over the mentioned timeframe. This growth can be attributed to various factors such as advancements in healthcare, an aging population, increased prevalence of chronic diseases requiring injectable treatments, and the rise in pharmaceutical research and development activities focused on injectable drug formulations.
About 65% of the total pharmaceutical packaging in India is for oral solid drugs followed by liquid oral drugs (around 25%).
The statistic suggests that a significant portion of pharmaceutical packaging in India is dedicated to oral solid drugs, comprising approximately 65% of the total packaging volume. This indicates a high demand for solid oral medications in the market. Following closely behind are liquid oral drugs, accounting for around 25% of the packaging. This data highlights the prevalence of oral medications in the pharmaceutical industry in India and underscores the importance of efficient packaging processes to cater to the diverse needs of patients consuming these oral drugs.
Packaging for over-the-counter (OTC) products is projected to experience a CAGR of 5.1% from 2018 to 2025.
This statistic indicates that the packaging industry for over-the-counter (OTC) products is expected to grow consistently at a Compound Annual Growth Rate (CAGR) of 5.1% from the year 2018 to 2025. The CAGR is a measure used to represent the annual growth rate of an investment over a specified time period, in this case, the packaging sector within the OTC products market. The projected growth rate of 5.1% suggests that there is a strong demand for improved and innovative packaging solutions for OTC products, which may be driven by factors such as consumer preferences, regulatory requirements, and advancements in packaging technology. This growth forecast could be valuable for companies operating in the packaging industry for OTC products to strategically plan for future investments and developments in this sector.
The pharmaceutical packaging industry is focusing on sustainable packaging that can be recycled or re-used without losing its quality.
The statistic suggests that the pharmaceutical packaging industry is currently prioritizing the development and implementation of sustainable packaging solutions that have minimal impact on the environment. Specifically, the industry is concentrating on creating packaging materials that can be easily recycled or reused without sacrificing their quality or integrity. This shift towards sustainable packaging not only aligns with growing consumer and regulatory demands for environmentally friendly practices, but also reflects the industry’s commitment to reducing waste and promoting resource conservation. By embracing sustainable packaging solutions, the pharmaceutical industry is taking proactive steps to minimize its environmental footprint and contribute to a more sustainable future.
Blister packaging is the fastest-growing product segment in the pharmaceutical packaging market.
The statistic “Blister packaging is the fastest-growing product segment in the pharmaceutical packaging market” indicates that among all the different types of packaging used for pharmaceutical products, blister packaging is experiencing the highest rate of growth in terms of demand and popularity. This may be attributed to various factors such as the convenience, safety, and tamper-evident nature of blister packaging, as well as the increasing emphasis on patient adherence to medication regimens. The growth of blister packaging in the pharmaceutical sector may also be driven by advancements in technology and materials that enhance the quality and effectiveness of this type of packaging. Overall, this statistic suggests that blister packaging is a key player in the evolving landscape of pharmaceutical packaging and is likely to continue gaining market share in the industry.
The biologics market, with demands for novel packaging solutions, grew to represent over 25% of the pharmaceutical industry in 2020.
The statistic indicates that the biologics market, characterized by the need for innovative packaging solutions, expanded significantly in 2020, making up more than a quarter of the pharmaceutical industry. This growth implies a surge in demand for biologic drugs, which are typically derived from living organisms and are often more complex to manufacture and store than traditional pharmaceutical products. The emphasis on novel packaging solutions suggests that companies in the biologics market are looking to improve product stability, safety, and convenience for patients. The substantial market share held by biologics highlights their increasing importance within the pharmaceutical sector, reflecting advancements in biotechnology and the rising popularity of precision medicines designed to target specific diseases and individual patient profiles.
The global pharmaceutical glass packaging market size was valued at USD 4.4 billion in 2020 and is expected to expand at a CAGR of 8.2% from 2021 to 2028.
The statistic provided states that the global pharmaceutical glass packaging market was worth USD 4.4 billion in 2020 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.2% from 2021 to 2028. This indicates that the market is anticipated to increase steadily over the forecasted period. The initial value in 2020 serves as a baseline for measuring the growth, with the CAGR representing the annual rate of growth that can be expected. This information is valuable for stakeholders in the pharmaceutical industry, as it highlights the current market size and the anticipated expansion of the pharmaceutical glass packaging sector in the coming years.
In 2019, Germany dominated Europe’s pharmaceutical packaging market with over 25% market share.
The statistic indicates that in 2019, Germany held a significant share of the pharmaceutical packaging market in Europe, accounting for over 25% of the total market. This dominance suggests that Germany was a major player in the production and distribution of pharmaceutical packaging materials within the region during that year. The high market share could be attributed to factors such as the country’s advanced manufacturing capabilities, a strong regulatory environment, and its position as a key player in the pharmaceutical industry. This statistic highlights Germany’s leadership position in the European pharmaceutical packaging market and underscores its importance in the industry for that particular year.
References
0. – https://www.www.mordorintelligence.com
1. – https://www.www.prnewswire.com
2. – https://www.www.packagingworld.com
3. – https://www.www.gminsights.com
4. – https://www.www.alliedmarketresearch.com
5. – https://www.www.grandviewresearch.com
6. – https://www.www.globenewswire.com
7. – https://www.www.packagingstrategies.com
